Trumpian “Common Sense” and the History of IQ Tests
By Pepper Stetler,
Los Angeles Review of Books
| 05. 08. 2025
"Donald Trump Signs The Pledge" by Michael Vadon
is licensed under CC BY-SA 2.0.
This is the eighth installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. The series is organized by Osagie K. Obasogie in collaboration with the Los Angeles Review of Books, and supported by the Center for Genetics and Society, the Othering & Belonging Institute, and Berkeley Public Health.
AT A PRESS CONFERENCE on January 30, 2025, the morning after a tragic midair collision in Washington, DC, between a military helicopter and an American Airlines plane, President Donald Trump rationalized the crash by invoking the Federal Aviation Administration’s attempts to diversify its workforce. “The FAA is actively recruiting workers who suffer severe intellectual disabilities, psychiatric problems, and other mental and physical conditions under a diversity and inclusion hiring initiative spelled out on the agency’s website.” Citing no evidence that diversity programs had anything to do with the accident, which killed 67 people, his point—presumably—was...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
By Emma Cieslik, Ms. Magazine | 11.20.2025
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...